A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
Clinical trial NCT04159519 · COMPLETED
Trial details
- NCT number
- NCT04159519
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2023-01-31
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.